Laduviglusib (CHIR-99021) (GMP) is Laduviglusib (HY-10182) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Laduviglusib is a potent, orally active and selective GSK-3alpha/beta inhibitor.
Molekulargewicht:
465.34
CAS Nummer:
[252917-06-9]
Formel:
C22H18Cl2N8
Target-Kategorie:
Autophagy,GSK-3,Wnt,beta-catenin
Anwendungsbeschreibung:
MCE Product type: GMP Small Molecules
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten